Hubei Hongyuan Pharmaceutical Technology Co., Ltd. Stock

Equities

301246

CNE100005ZB9

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-05-09 pm EDT 5-day change 1st Jan Change
17.94 CNY +2.05% Intraday chart for Hubei Hongyuan Pharmaceutical Technology Co., Ltd. +10.06% -30.95%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2022 2.06B 286M Sales 2023 2.05B 284M Capitalization 10.39B 1.44B
Net income 2022 435M 60.21M Net income 2023 87M 12.04M EV / Sales 2022 * -
Net cash position 2022 51.05M 7.07M Net cash position 2023 1.83B 253M EV / Sales 2023 4.17 x
P/E ratio 2022 *
-
P/E ratio 2023
116 x
Employees 2,075
Yield 2022 *
-
Yield 2023
0.19%
Free-Float 37.32%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.05%
1 week+10.06%
Current month+10.06%
1 month+0.96%
3 months-12.36%
6 months-35.88%
Current year-30.95%
More quotes
1 week
16.39
Extreme 16.39
18.90
1 month
14.16
Extreme 14.16
18.90
Current year
14.16
Extreme 14.16
26.30
1 year
14.16
Extreme 14.16
37.74
3 years
14.16
Extreme 14.16
45.00
5 years
14.16
Extreme 14.16
45.00
10 years
14.16
Extreme 14.16
45.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 -
Chairman 59 -
Director of Finance/CFO 39 -
Members of the board TitleAgeSince
Director/Board Member 64 -
Director/Board Member 54 -
Founder 64 02-01-20
More insiders
Date Price Change Volume
24-05-10 17.94 +2.05% 25,233,370
24-05-09 17.58 +2.75% 17,360,230
24-05-08 17.11 +2.33% 12,261,910
24-05-07 16.72 +0.24% 5,520,625

End-of-day quote Shenzhen S.E., May 09, 2024

More quotes
Hubei Hongyuan Pharmaceutical Technology Co Ltd is a China-based company mainly engaged in the research and development, production and sales of organic chemical raw materials, pharmaceutical intermediates, raw materials and pharmaceutical preparations. The Company is also engaged in the production of lithium hexafluorophosphate, one of the main materials for lithium battery electrolyte. The Company's main products are divided into organic chemical raw materials such as glyoxal in the ethylene glycol reaction chain, pharmaceutical intermediates such as glyoxylic acid, 2-methyl-5-nitroimidazole and other products, and raw materials such as metronidazole; Pharmaceutical intermediates guanine, diacetylguanine and other products in the reaction chain of methyl cyanoacetate and guanidine hydrochloride. The Company distributes its products in the domestic market and overseas markets.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. 301246 Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW